Distal Factors Associated With Proximal Overdose Risk Behaviors and Recent Non-Fatal Overdose Among a Sample of People Who Use Illicit Opioids in New York City
Restricted accessResearch articleFirst published online July, 2024
Distal Factors Associated With Proximal Overdose Risk Behaviors and Recent Non-Fatal Overdose Among a Sample of People Who Use Illicit Opioids in New York City
This analysis identifies factors associated with overdose risk behaviors and non-fatal overdose among a sample of 577 adult-age people who use illicit opioids and live in NYC. Survey data--which included outcome measures assessing (1) past 30-day non-fatal overdose and past 30-day overdose-related risk behaviors and (2) predictors representing potential risk and protective factors—were analyzed using bivariate and Poisson regression techniques. Results indicate being 41–56 years in age, being widowed, using cannabis, injecting, and having greater pain severity and mental health challenges were associated with greater risks. Current employment, homelessness, and prescription of medications for opioid use disorder were associated with fewer risks. Being 57+ was negatively associated with past-month overdose; higher pain severity and opioid related withdrawal were positively related, as were employment, cannabis use, and injection. Findings suggest the importance of expanding access to MOUD and tailoring OD prevention interventions for mental health and pain management services.
AlexanderM. J.KiangM. V.BarbieriM. (2018). Trends in black and white opioid mortality in the United States, 1979–2015. Epidemiology (Cambridge, Mass), 29(5), 707–715, https://doi.org/10.1097/EDE.0000000000000858
2.
AltekruseS. F.CosgroveC. M.AltekruseW. C.JenkinsR. A.BlancoC. (2020). Socioeconomic risk factors for fatal opioid overdoses in the United States: Findings from the mortality disparities in American communities study (MDAC). PloS One, 15(1), e0227966. https://doi.org/10.1371/journal.pone.0227966
3.
AshrafiounL.BohnertA. S. B.JannauschM.IlgenM. A. (2015). Evaluation of the current opioid misuse measure among substance use disorder treatment patients. Journal of Substance Abuse Treatment, 55, 15–20. https://doi.org/10.1016/j.jsat.2015.02.007
4.
BarbalatG.ReddyG.FranckN. (2022). Association of globalization with the burden of opioid use disorders 2019. A country-level analysis using targeted maximum likelihood estimation.
5.
BarocasJ. A.WangJ.MarshallB. D. L.LaRochelleM. R.BettanoA.BernsonD.BeckwithC. G.LinasB. P.WalleyA. Y. (2019). Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug and Alcohol Dependence, 200, 59–63. https://doi.org/10.1016/j.drugalcdep.2019.03.014
6.
BarthK. S.BallietW.PelicC. M.MadanA.MalcolmR.AdamsD.MorganK.OwczarskiS.BorckardtJ. J. (2014). Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain. Pain Medicine, 15(8), 1359–1364. https://doi.org/10.1111/pme.12403
7.
BeletskyL.BakerP.ArredondoJ.EmukaA.Goodman-MezaD.Medina-MoraM. E.WerbD.DavidsonP.AmonJ. J.StrathdeeS.Magis-RodriguezC. (2018). The global health and equity imperative for safe consumption facilities. Lancet (London, England), 392(10147), 553–554. https://doi.org/10.1016/S0140-6736(18)31469-7
8.
BennettA. S.ElliottL.GolubA.Wolfson-StofkoB.GuarinoH. (2017). Opioid-involved overdose among male Afghanistan/Iraq-Era U.S. Military veterans: A multidimensional perspective. Substance Use & Misuse, 1–11.
9.
BennettA. S.WatfordJ. A.ElliottL.Wolfson-StofkoB.GuarinoH. (2019). Military veterans' overdose risk behavior: Demographic and biopsychosocial influences. Addictive Behaviors, 99, 106036. https://doi.org/10.1016/j.addbeh.2019.106036
10.
BlancoC.VolkowN. D. (2019). Management of opioid use disorder in the USA: Present status and future directions. Lancet (London, England), 393(10182), 1760–1772. https://doi.org/10.1016/S0140-6736(18)33078-2
11.
BluthenthalR. N.SimpsonK.CeasarR. C.ZhaoJ.WengerL.KralA. H. (2020). Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug and Alcohol Dependence, 211, 107932. https://doi.org/10.1016/j.drugalcdep.2020.107932
12.
BoehnkeK. F.LitinasE.ClauwD. J. (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. The Journal of Pain, 17(6), 739–744. https://doi.org/10.1016/j.jpain.2016.03.002
13.
BoeriM. W. (2004). Hell, I'm an addict, but i ain't no junkie": An ethnographic analysis of aging heroin users. Human Organization, 236–245.
14.
ButlerS. F.BudmanS. H.FernandezK. C.HouleB.BenoitC.KatzN.JamisonR. N. (2007). Development and validation of the current opioid misuse measure. Pain, 130(1–2), 144–156. https://doi.org/10.1016/j.pain.2007.01.014
15.
CarterG. T.FlanaganA. M.EarleywineM.AbramsD. I.AggarwalS. K.GrinspoonL. (2011). Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. The American Journal of Hospice & Palliative Care, 28(5), 297–303. https://doi.org/10.1177/1049909111402318
16.
CastañedaA. M.LeeC.-S.KimY.-C.LeeD.MoonJ. Y. (2018). Addressing opioid-related chemical coping in long-term opioid therapy for chronic noncancer pain: A multicenter, observational, cross-sectional study. Journal of Clinical Medicine, 7(10), 354. https://doi.org/10.3390/jcm7100354
Centers for Disease Control and Prevention (CDC) (2023) National overdose deaths involving any opioid, number among all ages, by gender, 1999-2021. CDC WONDER, National center for health statistics, multiple causes of death 1999-2021.
CleelandC. S.RyanK. (1991). The brief pain inventory. Pain Research Group, 143–147.
22.
ClelandC. M.BennettA. S.ElliottL.RosenblumA.BrittonP. C.Wolfson-StofkoB. (2020). Between-and within-person associations between opioid overdose risk and depression, suicidal ideation, pain severity, and pain interference. Drug and Alcohol Dependence, 206, 107734, https://doi.org/10.1016/j.drugalcdep.2019.107734
23.
ColledgeS.PeacockA.LeungJ.LarneyS.GrebelyJ.HickmanM.CunninghamE.TrickeyA.StoneJ.VickermanP.DegenhardtL. (2019). The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis. The International Journal on Drug Policy, 73, 172–184, https://doi.org/10.1016/j.drugpo.2019.07.030
CrawfordF. W.AronowP. M.ZengL.LiJ. (2018). Identification of homophily and preferential recruitment in respondent-driven sampling. American Journal of Epidemiology, 187(1), 153–160, https://doi.org/10.1093/aje/kwx208
DarkeS.RossJ.HallW. (1996). Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non‐fatal overdose. Addiction, 91(3), 405–411. https://doi.org/10.1046/j.1360-0443.1996.9134059.x
28.
FaupelC. E. (1991). Shooting dope: Career patterns of hard-core heroin users. University of Florida Press.
29.
FeingoldD.BrillS.Goor-AryehI.DelayahuY.Lev-RanS. (2018). The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study. Journal of Affective Disorders, 235, 293–302, https://doi.org/10.1016/j.jad.2018.04.058
30.
FraserS.ValentineK. (2008). Substance and substitution: Methadone subjects in liberal societies. Palgrave Macmillan.
31.
FriedmanJ. R.HansenH. (2022). Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry, 79(4), 379–381. https://doi.org/10.1001/jamapsychiatry.2022.0004
32.
FriedmanS. R.KrawczykN.PerlmanD. C.Mateu-GelabertP.OmpadD. C.HamiltonL.NikolopoulosG.GuarinoH.CerdáM. (2020). The opioid/overdose crisis as a dialectics of pain, despair, and one-sided struggle. Frontiers in Public Health, 8, 540423. https://doi.org/10.3389/fpubh.2020.540423
33.
GoeslingJ.HenryM. J.MoserS. E.RastogiM.HassettA. L.ClauwD. J.BrummettC. M. (2015). Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. The Journal of Pain, 16(9), 844–851. https://doi.org/10.1016/j.jpain.2015.05.010
34.
GreenspanL. S.AlleyL.RiceS. P. M.OlsonR. (2021). Exploring biopsychosocial correlates of pain, pain management strategies, and risk for opioid misuse among home care workers in Washington State. Home Health Care Services Quarterly, 40(1), 54–74. https://doi.org/10.1080/01621424.2020.1810191
35.
HarrisD. R.EisingerC.WangY.DelcherC. (2020). IEEE International Conference on Big Data (Big Data), 2020, pp 3727–3736.
36.
HeckathornD. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44(2), 174–199. https://doi.org/10.1525/sp.1997.44.2.03x0221m
37.
HeckathornD. D.CameronC. J. (2017). Network sampling: From snowball and multiplicity to respondent-driven sampling. Annual Review of Sociology, 43(1), 101–119. https://doi.org/10.1146/annurev-soc-060116-053556
KhantzianE. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4(5), 231–244. https://doi.org/10.3109/10673229709030550
42.
KirshK. L.JassC.BennettD. S.HagenJ. E.PassikS. D. (2007). Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliative & Supportive Care, 5(3), 219–226. https://doi.org/10.1017/s1478951507000387
43.
LimJ. K.EarlywineJ. J.BagleyS. M.MarshallB. D. L.HadlandS. .E. (2021). Polysubstance involvement in opioid overdose deaths in adolescents and young adults, 1999-2018. JAMA Pediatrics, 175(2), 194–196. https://doi.org/10.1001/jamapediatrics.2020.5035
44.
LippoldK.AliB. (2020). Racial/ethnic differences in opioid-involved overdose deaths across metropolitan and non-metropolitan areas in the United States, 1999− 2017. Drug and Alcohol Dependence, 212, 108059. https://doi.org/10.1016/j.drugalcdep.2020.108059
45.
LivingstonM. D.BarnettT. E.DelcherC.WagenaarA. C. (2017). Recreational cannabis legalization and opioid-related deaths in Colorado, 2000–2015. American Journal of Public Health, 107(11), 1827–1829. https://doi.org/10.2105/AJPH.2017.304059
46.
LucasP.WalshZ. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. The International Journal on Drug Policy, 42, 30–35. https://doi.org/10.1016/j.drugpo.2017.01.011
47.
Mallery LankfordC.PaezK.YangM.LinA. (2022). Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA. Disability and Health Journal, 15(2S), 101296. https://doi.org/10.1016/j.dhjo.2022.101296
48.
McLeanK.KavanaughP. R. (2019). “They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine use in a time of treatment expansion. The International Journal on Drug Policy, 71, 118–124, https://doi.org/10.1016/j.drugpo.2019.06.019
49.
MitalS.WolffJ.CarrollJ. J. (2020). The relationship between incarceration history and overdose in North America: A scoping review of the evidence. Drug and Alcohol Dependence, 213, 108088. https://doi.org/10.1016/j.drugalcdep.2020.108088
50.
MuennigP. A.ReynoldsM.FinkD. S.ZafariZ.GeronimusA. T. (2018). America’s declining well-being, health, and life expectancy: Not just a white problem. American Journal of Public Health, 108(12), 1626–1631. https://doi.org/10.2105/AJPH.2018.304585
51.
NarrowW. E.ClarkeD. E.KuramotoS. J.KraemerH. C.KupferD. J.GreinerL.RegierD. A. (2013). DSM-5 field trials in the United States and Canada, Part III: Development and reliability testing of a cross-cutting symptom assessment for DSM-5. The American Journal of Psychiatry, 170(1), 71–82. https://doi.org/10.1176/appi.ajp.2012.12071000
NobleF.MarieN. (2018). Management of opioid addiction with opioid substitution treatments: Beyond methadone and buprenorphine. Frontiers in Psychiatry, 9, 742. https://doi.org/10.3389/fpsyt.2018.00742
55.
OlfsonM.WallM. M.LiuS.-M.BlancoC. (2018) Cannabis use and risk of prescription opioid use disorder in the United States. The American Journal of Psychiatry, 175(1), 47–53. https://doi.org/10.1176/appi.ajp.2017.17040413
56.
PagéM. G.SaïdiH.WareM. A.ChoinièreM. (2016). Risk of opioid abuse and biopsychosocial characteristics associated with this risk among chronic pain patients attending a multidisciplinary pain treatment facility. The Clinical Journal of Pain, 32(10), 859–869. https://doi.org/10.1097/AJP.0000000000000337
57.
PassikS.KirshK. L. (2008) Chemical coping. Pain and Chemical Dependency, 299.
58.
PeppinJ. F.RaffaR. B.SchatmanM. E. (2020) The polysubstance overdose-death crisis. Taylor & Francis. pp. 3405–3408.
59.
PougetE. R.BennettA. S.ElliottL.RosenblumA.BrittonP. C. (2017b). Recent overdose experiences in a community sample of military veterans who use opioids. Journal of Drug Issues, 47(3), 479–491. https://doi.org/10.1177/0022042617701255
60.
PougetE. R.BennettA. S.ElliottL.Wolfson-StofkoB.AlmeñanaR.BrittonP. C.RosenblumA. (2017a). Development of an opioid-related overdose risk behavior scale (ORBS). Substance Abuse, 38(3), 239–244. https://doi.org/10.1080/08897077.2017.1282914
61.
RiggK. K.MonnatS. M.ChavezM. N. (2018). Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies. The International Journal on Drug Policy, 57, 119–129. https://doi.org/10.1016/j.drugpo.2018.04.011
62.
SalganikM. J.HeckathornD. D. (2004). Sampling and Estimation in hidden populations using respondent-driven sampling. Sociological Methodology, 34(1), 193–240. https://doi.org/10.1111/j.0081-1750.2004.00152.x
StataCorp (2019). Stata statistical software: Release 16. StataCorp LLC.
65.
Substance Abuse and Mental Health Services Administration (SAMHSA) (2014). National survey on drug use and health: Summary of Methodological Studies, 1971–2014. samhsagov.
VyasM. B.LeBaronV. T.GilsonA. M. (2018). The use of cannabis in response to the opioid crisis: A review of the literature. Nursing Outlook, 66(1), 56–65. https://doi.org/10.1016/j.outlook.2017.08.012
68.
WieseB.Wilson-PoeA. R. (2018). Emerging evidence for cannabis' role in opioid use disorder. Cannabis and Cannabinoid Research, 3(1), 179–189. https://doi.org/10.1089/can.2018.0022
69.
YamamotoA.NeedlemanJ.GelbergL.KominskiG.ShoptawS.TsugawaY. (2019). Association between homelessness and opioid overdose and opioid-related hospital admissions/emergency department visits. Social Science & Medicine, 242, 112585. https://doi.org/10.1016/j.socscimed.2019.112585
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
